www.fgks.org »
Address
:
[go:
up one dir
,
main page
]
Include Form
Remove Scripts
Accept Cookies
Show Images
Show Referer
Rotate13
Base64
Strip Meta
Strip Title
Session Cookies
Contact TGA:
info@tga.gov.au
|
1800 020 653
|
More contact info
Translate
|
Subscribe
Therapeutic Goods Administration (TGA)
Australian Government Department of Health
Main menu
Home
Safety information
Report a problem or side effect
Reporting adverse events involving medicines, vaccines or medical devices
Report an issue with packaging or storage of a medicine
AEMS guidance for health professionals
AEMS guidance for sponsors
Help us promote adverse event reporting: promotional resources kit
Alerts
Current year alerts
All alerts
Recalls
About Australian recall actions
Recall actions database
Uniform recall procedure
Prescription opioids
Medicine shortages
Early warning system
Monitoring communications
About the Early Warning System
Early Warning System: consumer questions and answers
Early Warning System: health professional questions and answers
Black Triangle Scheme
Black Triangle Scheme: Information for sponsors
Safety information & education
Medicines safety
Medical devices safety
Database of Adverse Event Notifications (DAEN)
COVID-19
COVID-19 rapid antigen self-tests
COVID-19 treatments
COVID-19 treatments: Provisional determinations
Labels for COVID-19 treatments
Therapeutic Goods (Poisons Standard) (COVID-19 Treatment - Roche) (Casirivimab and Imdevimab) Labelling Exemption 2021
COVID-19 treatments: Provisional registrations
COVID-19 treatments: Treatments undergoing evaluation
COVID-19 treatments: Advertising compliance
COVID-19 treatments: Information for consumers and health professionals
COVID-19 treatments: Information for sponsors (industry)
COVID-19 vaccines
COVID-19 vaccine approval process
COVID-19 vaccines undergoing evaluation
Provisional registrations
COVID-19 vaccine safety monitoring and reporting
News and updates
COVID-19 vaccine advertising and import compliance
Information for consumers and health professionals
Information for sponsors (industry)
International collaboration
Consumers
Report a problem or side effect
Reporting adverse events involving medicines, vaccines or medical devices
Travelling with medicines and medical devices
Leaving Australia
Entering Australia
Helpful links for travellers
Buying medicines and medical devices online
Counterfeit medicines and devices
Can I import it?
Personal importation scheme
Medicinal cannabis: importation and the traveller's exemption
Medicines
How we regulate medicines
Prescription medicines
Complementary medicines
Over-the-counter (OTC) medicines
Vaccines
What's on my medicine label?
Accessing medicines during a medicines shortage
What ingredients are in my medicine?
Medical devices
Medical devices overview
Transvaginal (urogynaecological) surgical mesh hub
Breast implant hub
Cosmetic injections
Medical device cyber security
Advertising hub
Consumer information & education
Safety information for consumers
Medicines & medical devices
Community Q&A
MedSearch | Medicine information search app
Other web resources for consumers
Medicinal cannabis products
Health professionals
Report a problem or side effect
Reporting adverse events involving medicines, vaccines or medical devices
Accessing unapproved products
Special access scheme
Authorised prescribers
Clinical trials
Personal importation scheme
Medicine shortages: Information for Health Professionals
Accessing medicines during a medicine shortage
Medicinal cannabis
Nicotine vaping products
Advertising
Medicines
Labelling changes: information for health professionals
Registration of medicines for the medical termination of early pregnancy
Product Information
Prescribing medicines in pregnancy database
Medicine Shortages Information Initiative
Fast track approval pathways for prescription medicines
Medical devices
Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL)
Breast implant hub
Changes to labelling and regulation of hard surface disinfectants (commencing 1 April 2019)
Information for medical practitioners on pending up-classification of surgical mesh devices
Patient information material for implantable medical devices
Importing & supplying medical devices
Advice about medical devices for health professionals
Biologicals
Regulation of stem cell treatments: information for practitioners
Safety information
Medicines Safety Update
Medical Devices Safety Update
Australian Adverse Drug Reactions Bulletin
Medical device incident reporting & investigation scheme (IRIS) articles
Implanting medical devices
Other resources
Health professional information & education
Health professional educational materials
Industry
SME Assist
Regulation essentials
Workshops and events
Podcasts
SME guidance material
Educational videos
Interactive decision tools
Case studies
Useful resources for business
Understanding ingredient requirements
Regulation basics
How therapeutic goods are regulated in Australia
Australian Register of Therapeutic Goods
Industry educational materials
Legislation & legislative instruments
Advertising hub
Labelling & packaging
Ingredients in therapeutic goods
Exporting therapeutic goods
Importing therapeutic goods
Clinical trials
Cosmetics
International scientific guidelines
Safety information for industry
Medicine shortages
Advertising therapeutic goods
Getting started
Complying with advertising requirements
Learning resources
Enforcement and outcomes
News and reports
Consultation and independent reviews
Prescription medicines
Australian Regulatory Guidelines for Prescription Medicines
Prescription medicines regulation basics
Standards and guidelines
Forms for prescription medicine sponsors
Regulatory decisions and notices
Over-the-counter medicines
OTC medicines regulation basics
Standards, guidelines and publications
Forms for OTC medicine sponsors
Regulatory decisions and notices
Complementary medicines
Complementary medicine regulation basics
Standards, guidelines and publications
Forms for complementary medicine sponsors
Complementary medicines reforms
Regulatory decisions and notices
Sunscreens
Sunscreens regulation basics
Standards, guidelines and publications
Sunscreen reforms
Medical devices & IVDs
Australian conformity assessment bodies
Conformity assessment certificates, changes to requirements for certain medical devices
Determinations for Australian conformity assessment bodies
Face masks and COVID-19
Medical devices regulation basics
Unique Device Identification system
IVD medical devices regulation basics
Standards, guidelines and publications
Forms for medical device & IVD sponsors
Medical devices reforms
Regulatory decisions and notices
Biologicals
Australian Regulatory Guidelines for Biologicals
Regulatory framework for biologicals
Biological standards
Forms for the biologicals industry
Regulatory decisions and notices
Blood and blood components
Regulation of blood
Regulation of platelet-rich plasma (PRP), platelet-rich fibrin (PRF) and conditioned serum
Forms for the blood and blood components industry
Other therapeutic goods
Disinfectants, sterilants and sanitary products
Tampons & menstrual cups
Manufacturing therapeutic goods
Manufacturing basics
Manufacturing medicines
Manufacturing medical devices & IVDs
Manufacturing biologicals
Manufacturing blood and blood components
Manufacturing inspections
Forms for manufacturers
Notices for manufacturers
Notices about GMP clearance
Guidance on the management of GMP compliance signals
Scheduling of medicines & poisons
Scheduling basics
Scheduling committees meeting dates and decisions timeframes
The Poisons Standard (the SUSMP)
Public notices about scheduling
State/Territory scheduling information
About the TGA
TGA basics
Who we are & what we do
What the TGA doesn't do
Structure
TGA plans & reports
TGA reforms
Publications
Forms
Freedom of information
Acronyms & glossary
TGA Internet site
Social media
Contact the TGA
How can we help?
TGA customer service standards
Report a perceived breach or questionable practices
Website feedback or error reporting
Translate this website
Educational materials
For consumers
For health professionals
For industry
For university students
Education priorities 2018-19
Compliance and enforcement hub
Compliance management
Compliance actions and outcomes
News and information
Report a breach
Regulatory decisions & notices
Consent to import, supply or export goods that do not comply with standards
Cancellation requested by the sponsor - regulatory actions
Failure to pay annual charges - regulatory actions
TGA laboratory testing results
AUST numbers on medicine labels
S19A approval notices
Committees
TGA statutory advisory committees
Other committees
Employment & job vacancies
Working for the TGA
Recruitment information
Living in Canberra
Fees and payments
Schedule of fees and charges
Payment options
Information & notices about TGA fees & payments
Cost recovery implementation statements
Forms (fees and payments)
Annual Charge Exemption (ACE) scheme
TGA Business Services
TGA Business services: getting started with the TGA
TGA Business services - how to use the site
TGA Business Services forms
International
International activities
International cooperation
Use of international assessments
TGA international engagement strategy
Links to international agencies & organisations
TGA Internet site archive
Archived behind the news articles
Archived committee information
Archived consultations & reviews
Archived media releases
Archived newsletters and articles
Archived presentations
Archived regulatory decisions & notices
Archived TGA publications
News room
News & public notices
Latest news & updates
Media releases & statements
Behind the news
Newsletters & articles
Subscribe to updates
TGA tenders
TGA laboratory testing reports
Consultations & reviews
Open consultations & reviews
Closed consultations & reviews
About consultations
Consultation forecast
Medicines and Medical Devices Regulation Review
Events, training & presentations
Events & training
Presentations
Blog
TGA topics
Decrease the text size
Increase the text size
Print this page
Share
You are here
Home
»
Safety information
»
Alerts
Current year alerts
Related information
All alerts
About alerts
Medicines Safety Update
Medical Devices Safety Update
Subscribe to updates
November
October
September
August
July
June
May
April
March
February
January
November
S.W.A.G II Platinum 33K
4 November 2021
S.W.A.G II Platinum 33K products pose a serious risk to your health and should not be taken.
Panther Power Platinum 11000
4 November 2021
Panther Power Platinum 11000 capsules pose a serious risk to your health and should not be taken.
777K products
3 November 2021
777K products pose a serious risk to your health and should not be taken.
One Night Love tablets
3 November 2021
One Night Love tablets pose a serious risk to your health and should not be taken.
October
Shortages of tocilizumab (Actemra) medicines
14 October 2021
The TGA published an Actemra (tocilizumab) shortage - consumer information sheet produced by Pain Australia
Pentosan polysulfate sodium (Elmiron)
11 October 2021
Safety advisory - Risk of pigmentary maculopathy (changes in the retina of the eye), especially after long-term use
Discontinuation of DILAUDID hydromorphone hydrochloride 1mg/mL oral liquid
7 October 2021
Updated information regarding alternative overseas products approved for supply to address the discontinuation of DILAUDID liquid.
Laparoscopic power morcellators - Update 3
1 October 2021
Update
September
Substitution instrument to address shortage of Imdur Durules and Monodur Durules isosorbide mononitrate 120 mg modified release tablets
28 September 2021
The TGA has made an SSSI for isosorbide mononitrate 120mg modified release tablets to assist patients to access their medicine without delay.
Philips recall action for CPAP, Bi-Level PAP devices and mechanical ventilators
23 September 2021
Consumer and regulatory updates
CHATTANOOGA Ultrasound Gel Products and Lotions
14 September 2021
Recall due to risk of bacterial contamination
Caro white and Carotone products
8 September 2021
Various Caro white and Carotone branded products pose a risk to your health and should not be used.
August
Advice on the use of tocilizumab (Actemra) intravenous vials post expiry date during the COVID-19 pandemic
30 August 2021
Advice on using tocilizumab (Actemra) vials post expiry date
He Absolute King sachets
30 August 2021
He Absolute King sachets pose a serious risk to your health and should not be taken.
AB SLIM Slim-cellulose capsule
24 August 2021
AB-Slim Slim-cellulose capsules pose a serious risk to your health and should not be taken.
Azide impurity in 'sartan' blood pressure medicines
20 August 2021
TGA investigation - low levels of contamination with azidomethyl-biphenyl-tetrazole (AZBT)
Substitution instrument to address shortage of PROGYNOVA estradiol valerate tablets (multiple strengths)
12 August 2021
The TGA is advising health professionals and consumers of a current shortage for all strengths of PROGYNOVA estradiol valerate tablets.
Tocilizumab (Actemra) Serious Scarcity Substitution Instrument
6 August 2021
The TGA has published the first Serious Scarcity Substitution Instrument (SSSI) for tocilizumab (Actemra) to assist patients to access medicines during the shortage.
Varenicline
5 August 2021
TGA investigation - potential low levels of contamination with N-nitrosovarenicline
Black Ant King tablets
2 August 2021
Black Ant King tablets pose a serious risk to your health and should not be taken.
Neutrogena Ultra Sheer Body Mist Sunscreen Spray SPF 50+ (aerosol sunscreen)
2 August 2021
Recall - Possible presence of benzene
July
One Night Love tablets
30 July 2021
One Night Love tablets pose a serious risk to your health and should not be taken.
Gold Ant tablets
29 July 2021
Gold Ant tablets pose a serious risk to your health and should not be taken.
June
Novartis-Bio Somatropin Human Growth Hormone (HGH)
16 June 2021
Counterfeit Somatropin Human Growth Hormone (HGH) vials pose a serious risk to your health and should not be taken.
Ospolot (sulthiame) tablets 200 mg
3 June 2021
Product Defect Alert - child-resistant caps may not function correctly
Zostavax vaccine
2 June 2021
Safety measures to address risk of infection with the vaccine virus
May
Hydralyte Strawberry Kiwi Effervescent Electrolyte Tablets
21 May 2021
Recall due to unacceptable risk in pregnancy
April
Tandem t:slim X2 insulin pump
30 April 2021
Update - suspension lifted after review
AstraZeneca ChAdOx1-S COVID-19 vaccine
23 April 2021
Three additional Australian cases of TTS likely linked to vaccine
AstraZeneca ChAdOx1-S COVID-19 vaccine
16 April 2021
Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine
2021 seasonal influenza vaccines
13 April 2021
Information for consumers and health professionals
AstraZeneca ChAdOx1-S COVID-19 vaccine
13 April 2021
Second case of thrombosis with thrombocytopenia
LIFEPAK CR2 Defibrillator
6 April 2021
Product defect correction - lid magnet may dislodge and cause early battery depletion
March
Various medicines containing Artemisia annua and Artemisia absinthium
23 March 2021
Recall of various medicines containing Artemisia annua and Artemisia absinthium - updated recalled medicines
AstraZeneca ChAdOx1-S COVID-19 vaccine
19 March 2021
Update - European and UK reviews find no proven link with blood clots
AstraZeneca ChAdOx1-S COVID-19 vaccine
19 March 2021
Update - Expert review finds no evidence of increased risk of anaphylaxis
COVID-19 vaccines - safety and effectiveness in older adults
10 March 2021
Data on real-world use of COVID-19 vaccines approved in Australia provides reassurance about their safety in older people
New legislation to support medicine substitutions
5 March 2021
New legislation has been passed allowing pharmacists to substitute a medicine when the patient's usual medicine is in 'serious scarcity'.
TGA collecting COVID-19 vaccine side effect reports
1 March 2021
Safety monitoring
February
Shortage of sertraline tablets
16 February 2021
The TGA has issued a Serious Shortage Substitution Notice (SSSN) for sertraline tablets
Resurrection Male Sexual Enhancement Capsules
10 February 2021
Resurrection Male Sexual Enhancement capsules pose a serious risk to your health and should not be taken.
Pregabalin and gabapentin
1 February 2021
Safety advisory - enhanced warnings relating to abuse and dependence
January
Ergometrine maleate injection (500 microgram/mL) ampoule
21 January 2021
Alternative product approved to address expected shortage
Medicines containing Eucommia ulmoides (known as Du-Zhong or Tu-chung)
13 January 2021
Safety advisory – contains latex (statement includes Chinese translation 中文翻译)
The Therapeutic Goods Administration is part of the Health Products Regulation Group